ARTICLE | Clinical News
Peninsula starts HAP Phase III
June 10, 2004 7:00 AM UTC
Peninsula (Alameda, Calif.) started an international Phase III trial comparing its injectable doripenem to intravenous piperacillin/tazobactam to treat hospital-acquired pneumonia (HAP). The primary e...